Study on the Mechanism of ZhenQiFuZheng in the Treatment of Allergic Rhinitis Based on Intestinal Flora and Metabolites

Launched by THE FIRST AFFILIATED HOSPITAL WITH NANJING MEDICAL UNIVERSITY · May 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called ZhenQi FuZheng granules for people with allergic rhinitis, which is a condition that causes sneezing, runny nose, and other allergy symptoms. The researchers want to learn how this traditional Chinese medicine can help improve the immune system and reduce inflammation in the nose. They will collect samples and run tests on both animals and people to better understand how this treatment works and its effects on nasal inflammation.

To be eligible for this study, participants must be adults aged 18 to 65 who have been diagnosed with allergic rhinitis at a specific hospital. They will need to agree to provide samples and answer questions for research purposes. Those with other nasal diseases will not be included. Participants can expect to take the ZhenQi FuZheng granules and be monitored closely to see how their condition changes. This research may help develop better treatments for allergic rhinitis in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients (18-65 years).
• • Patients who visited the Department of Otolaryngology of the First Affiliated Hospital of Nanjing Medical University and are diagnosed as allergic rhinitis .
• Exclusion Criteria:
• • Patients who refused to accept specimen and questionnaire collection.
• • Patients who had nasal diseases other than allergic rhinitis, such as nasal papilloma and nasal malignant tumor.